Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph J Carter

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|November 11, 2006
Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactorsMargaret M Madeleine, Tarja Anttila, Stephen M Schwartz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2002
Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university studentsLong Fu Xi, Joseph J Carter, Denise A Galloway, et al.
Cancer Medicine|June 11, 2014
Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variantsMargaret M Madeleine, Joseph J Carter, Lisa G Johnson, et al.
Gynecologic Oncology|January 29, 2002
A population-based study of squamous cell vaginal cancer: HPV and cofactorsJanet R Daling, Margaret M Madeleine, Stephen M Schwartz, et al.
Cancer Research|October 21, 2010
Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patientsKelly G Paulson, Joseph J Carter, Lisa G Johnson, et al.
Surgical Innovation|May 19, 2006
Perioperative immunomodulation with Flt3 kinase ligand or a whole tumor cell vaccine is associated with a reduction in lung metastasis formation after laparotomy in miceJoseph J Carter, Daniel L Feingold, Anthony Oh, et al.
Vaccine|February 6, 2025
Term immune memory responses to human papillomavirus (HPV) vaccination following 2 versus 3 doses of HPV vaccineJoseph J Carter, Robin A Smith, Erin M Scherer, et al.
Ebiomedicine|July 18, 2016
A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected SubjectsErin M Scherer, Robin A Smith, Daniel F Gallego, et al.
Sexually Transmitted Diseases|February 10, 2016
Determinants of High-Risk Human Papillomavirus Seroprevalence and DNA Prevalence in Mid-Adult WomenPatricia Sadate-Ngatchou, Joseph J Carter, Stephen E Hawes, et al.
Journal of the National Cancer Institute|September 16, 2004
Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United StatesEric A Engels, Raphael P Viscidi, Denise A Galloway, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|November 11, 2006
Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactorsMargaret M Madeleine, Tarja Anttila, Stephen M Schwartz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2002
Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university studentsLong Fu Xi, Joseph J Carter, Denise A Galloway, et al.
Cancer Medicine|June 11, 2014
Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variantsMargaret M Madeleine, Joseph J Carter, Lisa G Johnson, et al.
Gynecologic Oncology|January 29, 2002
A population-based study of squamous cell vaginal cancer: HPV and cofactorsJanet R Daling, Margaret M Madeleine, Stephen M Schwartz, et al.
Cancer Research|October 21, 2010
Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patientsKelly G Paulson, Joseph J Carter, Lisa G Johnson, et al.
Surgical Innovation|May 19, 2006
Perioperative immunomodulation with Flt3 kinase ligand or a whole tumor cell vaccine is associated with a reduction in lung metastasis formation after laparotomy in miceJoseph J Carter, Daniel L Feingold, Anthony Oh, et al.
Vaccine|February 6, 2025
Term immune memory responses to human papillomavirus (HPV) vaccination following 2 versus 3 doses of HPV vaccineJoseph J Carter, Robin A Smith, Erin M Scherer, et al.
Ebiomedicine|July 18, 2016
A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected SubjectsErin M Scherer, Robin A Smith, Daniel F Gallego, et al.
Sexually Transmitted Diseases|February 10, 2016
Determinants of High-Risk Human Papillomavirus Seroprevalence and DNA Prevalence in Mid-Adult WomenPatricia Sadate-Ngatchou, Joseph J Carter, Stephen E Hawes, et al.
Journal of the National Cancer Institute|September 16, 2004
Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United StatesEric A Engels, Raphael P Viscidi, Denise A Galloway, et al.
Pageof 6